Oliver N. F. King Table 1 in Main Text), values derived from the same assay conditions were selected. 1 = most potent inhibitor. and AlkB (PDB ID: 4JHT). Red labels highlight residues from the AlkB complex structure. Two conformations were observed for both Tyr122 and Leu128 in the AlkB structure, which is likely due to the partial occupancy (50 %) of IOX1 in the active site. 
Recombinant Protein Production
PHD2, 19 25 were heterologously expressed in E. coli as described.
BBOX1 was expressed in Baculovirus as described.
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In Vitro Inhibition Assays
In vitro inhibition studies were carried using either AlphaScreen assays (PHD2, KDM4A/C/D/E, KDM3A, KDM6A/B, KDM2A, PHF8 and KDM5C), 22 formaldehyde dehydrogenase coupled assays (AlkB, 21 KDM6A), a fluoride detection based assay (BBOX1), 27 and MALDI-MS based assays (FIH, PHF8).
AlphaScreen Assays
AlphaScreen (Amplified Luminescence Proximity Homogeneous Assay) inhibition assays were carried out as previously reported. 22, 28 Assays were carried out in 384-well plates using white Proxiplates (Perkin Elmer). Hydroxyethyl-piperazine-ethane sulfonic acid (HEPES) buffer was purchased from Apollo Scientific. Ferrous ammonium sulphate (FAS) was made fresh in 20 mM HCl to a concentration of 400 mM and then diluted to 1 mM in deionised water. Bovine serum albumin (BSA) was free of fatty acid and globulin (Sigma A7030). AlphaScreen General IgG detection kit was purchased from Perkin Elmer. Biotinylated peptides were synthesised in house or purchased from GLS China (Shanghai, China) or Pepceuticals (Leicestershire, U.K.). Antibodies against peptide products were as previously reported. All other reagents were from Sigma-Aldrich. Protocols for the KDM2A, KDM3A, KDM4A/C, KDM5C, KDM6B and PHF8 assays were as previously reported. The KDM6A inhibition assay was carried out in a total volume of 10 μL containing KDM6A (200 nM), 2OG (10 μM), ferrous iron (10 μM), Biotin-H3(14-34)K27me3 peptide (250 nM), nonbiotinylated H3(14-34)K27me3 peptide (1 μM) and inhibitor (1 % DMSO in final reaction).
The reaction was stopped after 1 hour by addition of EDTA (30 mM) and the product peptide (biotinylated) was detected by addition of 5 μL of AlphaScreen donor and acceptor beads that previously had been incubated with the anti-dimethyl-Histone H3 (Lys27) antibody (Millipore 07-452). The sample was then left for 1 hour before analysis in a BMG Labtech Pherastar FS plate reader. Data were normalised to the no enzyme control and IC 50 values calculated from nonlinear regression curve fits using GraphPad Prism 5.
Formaldehyde Dehydrogenase (FDH) Coupled Assays
K M app values for 2OG with KDM6A and AlkB were determined using FDH coupled assays.
Samples (total volume 25 μL) were monitored over initial time points as described, and kinetic parameters were determined by plotting the Michaelis-Menten equation using GraphPad Prism 5. For KDM6A, samples contained KDM6A (2.5 μM), 2OG, nonbiotinylated H3(14-34)K27me3 peptide (500 μM), ferrous iron (50 μM), NAD (2 mM) and formaldehyde dehydrogenase (0.0125 units) in 50 mM HEPES 50 mM NaCl pH 7.5 buffer. AlkB samples contained AlkB (2 μM), 2OG, oligonucleotide containing 1-methyladenine (20 μM, sequence GC-1meA-AGGTCCCGTAGTGCG, ATD Bio, U.K.) ascorbate (100 μM), ferrous iron (10 μM), NAD (500 μM) and formaldehyde dehydrogenase (0.025 units) in 50 mM HEPES buffer pH 7.5. For AlkB inhibition assays, samples also contained inhibitor (2.5 μL). Enzyme, FDH and inhibitor were preincubated for 15 minutes prior to addition of other reagents. Data were normalised to the no enzyme control and IC 50 values calculated from nonlinear regression curve fits using GraphPad Prism 5.
MALDI-TOF Assays
Inhibition assays for FIH and PHF8 were carried out as follows. For FIH inhibition, samples (total volume 10 µL) containing FIH (1 µM), consensus ankyrin peptide (sequence HLEVVKLLLEAGADVNAQDK, 100 µM), 2OG (10 µM), ascorbate (100 µM), ferrous iron (10 µM) and inhibitor in 50 mM HEPES pH 7.5 buffer, were incubated for 5 minutes before quenching with MeOH (20 µL). Enzyme, ascorbate, ferrous iron and inhibitor were preincubated for 15 minutes prior to addition of substrate and 2OG. After quenching, aliquots of each sample (1 µL) were then mixed with 1 µL of 1 mg/mL α-cyano-4-hydroxycinnamic acid and assessed by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) Mass Spectrometry (Micromass). PHF8 samples (total volume 10 µL) contained PHF8 (2 µM), 2OG (15 µM), non-biotinylated H3(1-14)K4me3K9me2 peptide (10 µM), ascorbate (100 µM), ferrous iron (10 µM) and inhibitor in 100 mM HEPES 500 mM NaCl pH 7.5 buffer. Reactions were quenched after 10 minutes using MeOH (20 μL) before MALDI-MS analysis. Data were normalised to the no enzyme control and IC 50 values calculated from nonlinear regression curve fits using GraphPad Prism 5.
Crystallography
Recombinant forms of AlkB, 25 FIH, 20 KDM4A 9 and KDM6B 14 were expressed in Escherichia coli BL21 (DE3) and purified as reported. Crystals of AlkB, FIH, KDM4A and KDM6B in complex with IOX1/4C8HQ were grown in sitting drops under conditions described in Table S4 . In general, crystals were cryoprotected by transferring to a solution of mother liquor supplemented with 15-25 % v/v glycerol before being cyro-cooled in liquid N 2 . Data were collected from single crystals at 100K using synchrotron radiation at the Diamond Light Source (DLS) beamlines. The data were processed as outlined in Table S3 . Structures of AlkB, FIH and KDM4A were solved by molecular replacement using PHASER 29 or by isomorphous replacement using PHENIX 30 ; PDB ID 1H2K (for FIH), 3T4V
(for AlkB), 2OX0 (for KDM4A) were used as initial search models. A single wavelength anomalous dispersion (SAD) dataset was collected for KDM6B.IOX1 seleno-methionine derivatized crystal. The structure of KDM6B.IOX1 complex was solved as described. 14 Iterative rounds of model building and refinement using COOT 31 and PHENIX 30 and/or CNS 32 were performed until the decreasing R and R free no longer converged. All residues were in acceptable regions of Ramachandran plots as calculated by MolProbity. 33 Data collection and refinement statistics are shown in Table S3 . 
Theory and Computational Methods
Potential energy landscapes of IOX1 and 4C8HQ bound within the active site of KDM4A (PDB IDs: 3NJY and 4BIS respectively) were analyzed via the optimization of energy calculations using Schrödinger 9.0. Structure frameworks of the binding pockets are shown in Figure S8 . In each model, the chelating Ni(II) ion was replaced with Fe(II) to represent the biological systems. Quantum chemical calculations were carried out using density functional calculations with the 6-31G* basis set for all atoms. The M06 hybrid density functional was employed for all calculations. 34 This functional consists of meta-hybrid hybrid GGA DFT functional 35 and M06 family functionals which are parametrized including both transition metals and non-metals. Energy values for the KDM4A-IOX1 complex, the KDM4A-4C8HQ complex, KDM4A and the ligands respectively were calculated using energy minimization methods. The calculated energy difference between the KDM4A-IOX1 complex and the corresponding KDM4A-4C8HQ complex (Equation S1) was -7.98 Kcal mol -1 . 
Cell-Based Assays Constructs
Flag-tagged full length KDM4A 8 and KDM6B 14 were used for immunofluorescence assays.
Overexpression of wild type KDM2A resulted in perinucleolar foci and incomplete demethylation of histone 3 lysine-36Me2 throughout the nucleus. To distribute KDM2A and therefore its enzymatic activity more evenly throughout the nucleus we overexpressed KDM2A with a point mutation in the CXXC domain, K601A which abrogates KDM2A binding to unmethylated CpG dinucleotides.
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Cell culture
HeLa cells were cultured at 37 °C and 5 % CO 2 in RPMI 1640 medium (Sigma Aldrich) and supplemented with 10 % FCS (Invitrogen), 1 % Glutamax (Invitrogen), and 1 % Penicillinstreptomycin (Lonza). HeLa cells were seeded into 96-well clear-bottom optical-grade plates (BD Biosciences) at 8000 cells per well and allowed to settle overnight. The next day, the
medium was changed to antibiotics-free medium. For each well, 0.1 μg of plasmid and 0.25 μL of Lipofectamine 2000 (Invitrogen) were each incubated in 25 μL of OptiMEM (Invitrogen) for 5 minutes at room temperature. The two solutions were then combined and mixed gently but thoroughly and incubated for 20 minutes at room temperature. The mixture was then added to the cells. Four hours later, the medium was changed to regular culture medium with antibiotics and dosed with varying concentrations of compound. The amount of DMSO in each well was kept constant throughout the plate. The cells were incubated for a further 24 hours before being fixed for immunostaining.
Immunostaining
Cells were fixed in 4 % formaldehyde for 20 minutes, permeabilised in 0.5 % Triton-X 100 for 6-10 minutes, and blocked in 3 % FCS for 1 hour with a PBS wash in between each step. The primary antibodies were then added to the cells in blocking solution and left overnight. The next day, cells were washed 3 times in PBS, incubated with secondary antibodies for 1 hour, rinsed 3 times in PBS again, and counterstained with DAPI before imaging.
Imaging
Immunostained cells were imaged on the BD Pathway high content analyser (BD Biosciences). Briefly, the exposure time for DAPI, Alexafluor 488 and Alexafluor 568 was set up so as to utilise the entire 12-bit dynamic range. The system's autofocus and montage capture features were employed so as to automatically obtain multiple sharp images for each well, thus, increasing the sample size. After image acquisition, the data was imported and analysed in Attovision (BD Biosciences). Measurement of the fluorescence intensity of the Flag-tag and histone modification staining was restricted to the nucleus of each cell. The nuclei were automatically identified by DAPI staining. Cells expressing low amounts of the exogenous demethylase, where Flag-tag staining was dim, were omitted from analysis. Finally, the average intensity of the histone modification staining for the remaining cells in each well was exported to BD IDE (BD Biosciences) and Prism 5 (Graphpad) for plotting.
Chemical Synthesis
N-oxalylglycine (NOG) and dimethyloxalylglycine (DMOG) were synthesised as reported. 37 2,4-pyridinedicarboxylic acid (2,4-PDCA) was purchased from Aldrich. Dimethyl-2,4-pyridinedicarboxylate (dmPDCA) was synthesised from 2,4-PDCA as reported. 38 5-carboxy-8-hydroxyquinoline (IOX1) and 4-carboxy-8-hydroxyquinoline were synthesised as described below. Reagents and solvents were from Aldrich. TLC monitoring was performed using precoated aluminium-backed plates (Merck, silica 60 F254). Melting points were determined using a Leica Galen III hot-stage melting point apparatus and microscope. Infrared spectra were recorded on a Bruker Tensor 27 FT-IR spectrometer. NMR spectra were acquired using a Bruker DPX400 NMR spectrometer. Chemical shifts (δ) are given in ppm, and the multiplicities are given as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), broad (br). Coupling constants J are given in Hz (± 0.5 Hz). High resolution mass spectra (HRMS) were recorded using a Bruker MicroTOF spectrometer.
5-carboxy-8-hydroxyquinoline (IOX1)
Acrolein (0.65 mL, 9.73 mmol) was added dropwise to a refluxing solution of 3-amino-4-hydroxybenzoic acid (1.00 g, 6.53 mmol) in 6N HCl (15 mL) and stirred at reflux for 2 h. The reaction mixture was cooled to r. 
4-Carboxy-8-Sulfoquinoline
Fuming sulphuric acid (65 % SO 3 , 1 mL) was added dropwise to 4-quinolinecarboxylic acid (1 g, 5.68 mmol) inside a 10 mL microwave vial. The vial was sealed and the reaction mixture heated at 200 °C in a sand bath for 2 h. The mixture was left to cool down to room temperature and water (5 mL) was added dropwise. The black residue was triturated with water until formation of a homogenous white powder occurred. 
4-carboxy-8-hydroxyquinoline (4C8HQ)
8-Sulfoquinoline-4-carboxylic acid (1 g, 3.95 mmol) was dissolved in a solution of potassium hydroxide (5 g, 89.3 mmol) in water. The solvent was evaporated under reduced pressure.
The residue was heated above 300 °C with a heat gun until a colour change from off-white to dark yellow occurred. The residue was left to cool to room temperature and dissolved in water (200 mL). The pH was adjusted to 4.5 with aqueous hydrochloric acid and the solution was extracted with ethyl acetate (500 mL) three times. The combined organic layers were combined and dried over anhydrous 
